Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Associations between diabetes mellitus and pulmonary hypertension in chronic respiratory disease patients.

Takahashi T, Yoshihisa A, Sugimoto K, Yokokawa T, Misaka T, Kaneshiro T, Oikawa M, Kobayashi A, Nakazato K, Ishida T, Takeishi Y.

PLoS One. 2018 Oct 9;13(10):e0205008. doi: 10.1371/journal.pone.0205008. eCollection 2018.

2.

Predicting factors of transmural thermal injury after cryoballoon pulmonary vein isolation.

Matsumoto Y, Kaneshiro T, Hijioka N, Nodera M, Yamada S, Kamioka M, Yoshihisa A, Ohkawara H, Hikichi T, Suzuki H, Takeishi Y.

J Interv Card Electrophysiol. 2018 Sep 19. doi: 10.1007/s10840-018-0454-8. [Epub ahead of print]

PMID:
30232688
3.

A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis.

Kiko T, Yoshihisa A, Kanno Y, Yokokawa T, Abe S, Miyata-Tatsumi M, Misaka T, Oikawa M, Kobayashi A, Ishida T, Takeishi Y.

Int Heart J. 2018 Sep 26;59(5):996-1001. doi: 10.1536/ihj.17-695. Epub 2018 Aug 11.

4.

Feasibility of skin acetone analysis in patients with cardiovascular diseases.

Yokokawa T, Sato T, Suzuki S, Oikawa M, Yoshihisa A, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Fukushima J Med Sci. 2018 Aug 29;64(2):60-63. doi: 10.5387/fms.2018-03. Epub 2018 Jul 14.

5.

Urinary N-terminal fragment of titin is a marker to diagnose muscular dystrophy in patients with cardiomyopathy.

Yoshihisa A, Kiko T, Sato T, Oikawa M, Kobayashi A, Takeishi Y.

Clin Chim Acta. 2018 Sep;484:226-230. doi: 10.1016/j.cca.2018.06.001. Epub 2018 Jun 2.

6.

Association between Serum Uric Acid Level and Ventricular Tachyarrhythmia in Heart Failure Patients with Implantable Cardioverter-Defibrillator.

Nodera M, Suzuki H, Matsumoto Y, Kamioka M, Kaneshiro T, Yoshihisa A, Ohira T, Takeishi Y.

Cardiology. 2018;140(1):47-51. doi: 10.1159/000488851. Epub 2018 May 25.

PMID:
29804115
7.

Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure.

Yokokawa T, Sato T, Suzuki S, Oikawa M, Yoshihisa A, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Shimouchi A, Takeishi Y.

Int Heart J. 2018 Jul 31;59(4):808-812. doi: 10.1536/ihj.17-482. Epub 2018 May 23.

8.

Utility of heart rate turbulence and T-wave alternans to assess risk for readmission and cardiac death in hospitalized heart failure patients.

Yamada S, Yoshihisa A, Sato Y, Sato T, Kamioka M, Kaneshiro T, Oikawa M, Kobayashi A, Suzuki H, Ishida T, Takeishi Y.

J Cardiovasc Electrophysiol. 2018 Sep;29(9):1257-1264. doi: 10.1111/jce.13639. Epub 2018 Jun 6.

PMID:
29777559
9.

Relation of Testosterone Levels to Mortality in Men With Heart Failure.

Yoshihisa A, Suzuki S, Sato Y, Kanno Y, Abe S, Miyata M, Sato T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Am J Cardiol. 2018 Jun 1;121(11):1321-1327. doi: 10.1016/j.amjcard.2018.01.052. Epub 2018 Mar 1.

10.

Usefulness of Urinary N-Terminal Fragment of Titin to Predict Mortality in Dilated Cardiomyopathy.

Yoshihisa A, Kimishima Y, Kiko T, Sato Y, Watanabe S, Kanno Y, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Am J Cardiol. 2018 May 15;121(10):1260-1265. doi: 10.1016/j.amjcard.2018.01.046. Epub 2018 Feb 12.

11.

Association of Serum Zinc Level With Prognosis in Patients With Heart Failure.

Yoshihisa A, Abe S, Kiko T, Kimishima Y, Sato Y, Watanabe S, Kanno Y, Miyata-Tatsumi M, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

J Card Fail. 2018 Jun;24(6):375-383. doi: 10.1016/j.cardfail.2018.02.011. Epub 2018 Mar 2.

12.

Association between sleep-disordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction.

Suzuki S, Yoshihisa A, Sato Y, Watanabe S, Yokokawa T, Sato T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Takeishi Y.

ESC Heart Fail. 2018 Jun;5(3):284-291. doi: 10.1002/ehf2.12273. Epub 2018 Feb 20.

13.

VEGF165b elevation in pulmonary arterial hypertension patients, causative or adaptive? -Reply.

Yoshihisa A, Suzuki S, Takeishi Y.

Int J Cardiol. 2018 Apr 1;256:32. doi: 10.1016/j.ijcard.2017.11.042. No abstract available.

PMID:
29454413
14.

Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.

Yoshihisa A, Kimishima Y, Kiko T, Sato Y, Watanabe S, Kanno Y, Abe S, Miyata-Tatsumi M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Ishida T, Takeishi Y.

Int J Cardiol. 2018 May 1;258:269-274. doi: 10.1016/j.ijcard.2018.01.138. Epub 2018 Feb 8.

PMID:
29428236
15.

Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.

Yoshihisa A, Sato Y, Sato T, Suzuki S, Oikawa M, Takeishi Y.

BMC Cardiovasc Disord. 2018 Jan 25;18(1):11. doi: 10.1186/s12872-018-0746-z.

16.

Impact of nutritional indices on mortality in patients with heart failure.

Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Ishida T, Takeishi Y.

Open Heart. 2018 Jan 9;5(1):e000730. doi: 10.1136/openhrt-2017-000730. eCollection 2018.

17.

Impact of Anemia on Left Ventricular Reverse Remodeling in Response to Carvedilol.

Yoshihisa A.

Circ J. 2018 Feb 23;82(3):646-647. doi: 10.1253/circj.CJ-17-1362. Epub 2018 Jan 17. No abstract available.

18.

Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.

Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Tang WHW, Grodin J, Passino C, Emdin M.

Circulation. 2018 Jan 16;137(3):286-297. doi: 10.1161/CIRCULATIONAHA.117.031560. Review.

PMID:
29335288
19.

Subclinical Hypothyroidism Is Associated With Adverse Prognosis in Heart Failure Patients.

Sato Y, Yoshihisa A, Kimishima Y, Kiko T, Watanabe S, Kanno Y, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Can J Cardiol. 2018 Jan;34(1):80-87. doi: 10.1016/j.cjca.2017.10.021. Epub 2017 Nov 8.

20.

Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus.

Yokokawa T, Sato T, Suzuki S, Oikawa M, Yoshihisa A, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Shimouchi A, Takeishi Y.

BMC Cardiovasc Disord. 2017 Nov 16;17(1):280. doi: 10.1186/s12872-017-0713-0.

21.

Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.

Sato T, Yoshihisa A, Kanno Y, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Takeishi Y.

Eur J Prev Cardiol. 2017 Dec;24(18):1979-1987. doi: 10.1177/2047487317739079. Epub 2017 Oct 31.

PMID:
29086584
22.

Novel Parameter to Predict Left Ventricular Filling Pressure: Product of Log B-Type Natriuretic Peptide and Ratio of Mitral Inflow Early and Late Diastolic Filling Velocities.

Oikawa M, Kobayashi A, Wada K, Sato T, Suzuki S, Yoshihisa A, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Takeishi Y.

J Card Fail. 2018 Jan;24(1):29-32. doi: 10.1016/j.cardfail.2017.10.008. Epub 2017 Oct 12.

PMID:
29031870
23.

Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.

Yoshihisa A, Sato Y, Yokokawa T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2018 Apr;5(2):262-270. doi: 10.1002/ehf2.12222. Epub 2017 Oct 2.

24.

Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure.

Yokokawa T, Ichijo Y, Houtsuki Y, Matsumoto Y, Oikawa M, Yoshihisa A, Sugimoto K, Nakazato K, Suzuki H, Saitoh SI, Shimouchi A, Takeishi Y.

Int Heart J. 2017 Oct 21;58(5):828-830. doi: 10.1536/ihj.16-556. Epub 2017 Sep 30.

25.

Autoimmune disease mouse model exhibits pulmonary arterial hypertension.

Sugimoto K, Nakazato K, Sato A, Suzuki S, Yoshihisa A, Machida T, Saitoh SI, Sekine H, Takeishi Y.

PLoS One. 2017 Sep 19;12(9):e0184990. doi: 10.1371/journal.pone.0184990. eCollection 2017.

26.

Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET/MRI.

Kiko T, Masuda A, Nemoto A, Tominaga H, Oriuchi N, Yoshihisa A, Takeishi Y.

J Nucl Cardiol. 2018 Apr;25(2):685-687. doi: 10.1007/s12350-017-1066-x. Epub 2017 Sep 14. No abstract available.

PMID:
28913789
27.

The CHA2 DS2 -VASc score as a predictor of high mortality in hospitalized heart failure patients.

Yoshihisa A, Watanabe S, Kanno Y, Takiguchi M, Sato A, Yokokawa T, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2016 Dec;3(4):261-269. doi: 10.1002/ehf2.12098. Epub 2016 Jul 18.

PMID:
28834660
28.

Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction.

Yoshihisa A, Watanabe S, Yokokawa T, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Takeishi Y.

ESC Heart Fail. 2017 Aug;4(3):360-364. doi: 10.1002/ehf2.12176. Epub 2017 Jun 26.

29.

Heart failure and sleep disordered breathing.

Yoshihisa A, Takeishi Y.

Fukushima J Med Sci. 2017 Aug 9;63(2):32-38. doi: 10.5387/fms.2017-13. Epub 2017 Jul 21. Review.

30.

Pulmonary Artery Diameter Predicts Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Sugimoto K, Nakazato K, Sakamoto N, Yamaki T, Kunii H, Yoshihisa A, Suzuki H, Saitoh SI, Takeishi Y.

Int Heart J. 2017 Aug 3;58(4):584-588. doi: 10.1536/ihj.16-365. Epub 2017 Jul 13.

31.

Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.

Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.

Open Heart. 2017 Apr 28;4(1):e000598. doi: 10.1136/openhrt-2017-000598. eCollection 2017.

32.

Anatomical predisposing factors of transmural thermal injury after pulmonary vein isolation.

Kaneshiro T, Matsumoto Y, Nodera M, Kamioka M, Kamiyama Y, Yoshihisa A, Ohkawara H, Suzuki H, Takeishi Y.

Europace. 2018 Jul 1;20(7):1122-1128. doi: 10.1093/europace/eux185.

PMID:
28605437
33.

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure.

Yoshihisa A, Sato Y, Watanabe S, Yokokawa T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Takeishi Y.

BMC Cardiovasc Disord. 2017 May 31;17(1):141. doi: 10.1186/s12872-017-0577-3.

34.

Clinical features of extremely elderly patients with heart failure.

Yokokawa T, Yoshihisa A, Kanno Y, Sato T, Suzuki S, Misaka T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

Geriatr Gerontol Int. 2017 Nov;17(11):2194-2199. doi: 10.1111/ggi.13060. Epub 2017 May 21.

PMID:
28544166
35.

Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.

Yoshihisa A, Takiguchi M, Kanno Y, Sato A, Yokokawa T, Miura S, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

J Am Heart Assoc. 2017 May 16;6(5). pii: e005110. doi: 10.1161/JAHA.116.005110.

36.

Heterogeneous impact of body mass index on in-hospital mortality in acute heart failure syndromes: An analysis from the ATTEND Registry.

Yoshihisa A, Sato T, Kajimoto K, Sato N, Takeishi Y; Acute Decompensated Heart Failure Syndromes (ATTEND) investigators.

Eur Heart J Acute Cardiovasc Care. 2017 Mar 1:2048872617703061. doi: 10.1177/2048872617703061. [Epub ahead of print]

PMID:
28361568
37.

Plasma volume status predicts prognosis in patients with acute heart failure syndromes.

Yoshihisa A, Abe S, Sato Y, Watanabe S, Yokokawa T, Miura S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Saitoh SI, Takeishi Y.

Eur Heart J Acute Cardiovasc Care. 2018 Jun;7(4):330-338. doi: 10.1177/2048872617690889. Epub 2017 Jan 31.

PMID:
28139135
38.

Insomnia and Cardiac Events in Patients With Heart Failure - Reply.

Yoshihisa A, Kanno Y, Takeishi Y.

Circ J. 2016 Dec 22;81(1):126. doi: 10.1253/circj.CJ-16-1198. Epub 2016 Dec 14. No abstract available.

39.

Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.

Sugimoto K, Yoshihisa A, Nakazato K, Jin Y, Suzuki S, Yokokawa T, Misaka T, Yamaki T, Kunii H, Suzuki H, Saitoh SI, Takeishi Y.

PLoS One. 2016 Nov 22;11(11):e0165603. doi: 10.1371/journal.pone.0165603. eCollection 2016.

40.

The CHA2DS2-VASc score as a predictor of high mortality in hospitalized heart failure patients.

Yoshihisa A, Watanabe S, Kanno Y, Takiguchi M, Sato A, Yokokawa T, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2016 Dec;3(4):261-269. Epub 2016 Jul 18.

41.

Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus.

Sato A, Yoshihisa A, Kanno Y, Takiguchi M, Miura S, Shimizu T, Nakamura Y, Yamauchi H, Owada T, Sato T, Suzuki S, Oikawa M, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2016 Jun;3(2):77-85. Epub 2015 Nov 30.

42.

Prognostic Impact of Living in Temporary Housing in Fukushima After the Great East Japan Earthquake.

Suzuki S, Yoshihisa A, Kanno Y, Watanabe S, Takiguchi M, Miura S, Yokokawa T, Sato T, Oikawa M, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

J Card Fail. 2017 Jan;23(1):90-92. doi: 10.1016/j.cardfail.2016.10.003. Epub 2016 Oct 18. No abstract available.

PMID:
27769908
43.

Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension.

Suzuki S, Yoshihisa A, Yokokawa T, Misaka T, Sakamoto N, Sugimoto K, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.

Int J Cardiol. 2016 Nov 1;222:416-420. doi: 10.1016/j.ijcard.2016.07.277. Epub 2016 Aug 1.

PMID:
27505326
44.

Prognostic Significance of Insomnia in Heart Failure.

Kanno Y, Yoshihisa A, Watanabe S, Takiguchi M, Yokokawa T, Sato A, Miura S, Shimizu T, Nakamura Y, Abe S, Sato T, Suzuki S, Oikawa M, Saitoh S, Takeishi Y.

Circ J. 2016 Jun 24;80(7):1571-7. doi: 10.1253/circj.CJ-16-0205. Epub 2016 May 19.

45.

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.

Oikawa M, Sakamoto N, Kobayashi A, Suzuki S, Yoshihisa A, Yamaki T, Nakazato K, Suzuki H, Saitoh S, Kiko Y, Nakano H, Hayashi T, Kimura A, Takeishi Y.

BMC Cardiovasc Disord. 2016 May 10;16:83. doi: 10.1186/s12872-016-0262-y.

46.

Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.

Watanabe S, Yoshihisa A, Kanno Y, Takiguchi M, Yokokawa T, Sato A, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

J Card Fail. 2016 Dec;22(12):962-969. doi: 10.1016/j.cardfail.2016.04.017. Epub 2016 Apr 29.

47.

Prognostic significance of periodic leg movements during sleep in heart failure patients.

Yoshihisa A, Suzuki S, Kanno Y, Takiguchi M, Sato A, Miura S, Masuda A, Yokokawa T, Shimizu T, Nakamura Y, Yamauchi H, Owada T, Abe S, Sato T, Oikawa M, Saitoh S, Takeishi Y.

Int J Cardiol. 2016 Jun 1;212:11-3. doi: 10.1016/j.ijcard.2016.03.007. Epub 2016 Mar 15. No abstract available.

PMID:
27015642
48.

Plasma Levels of Receptor for Advanced Glycation End-Products and High-Mobility Group Box 1 in Patients With Pulmonary Hypertension.

Suzuki S, Nakazato K, Sugimoto K, Yoshihisa A, Yamaki T, Kunii H, Suzuki H, Saitoh S, Takeishi Y.

Int Heart J. 2016;57(2):234-40. doi: 10.1536/ihj.15-188. Epub 2016 Mar 11.

49.

The association between circulating anti-angiogenic isoform of vascular endothelial growth factor and clinical profiles in patients with peripheral artery disease.

Sato A, Yoshihisa A, Yokokawa T, Shimizu T, Nakamura Y, Misaka T, Kamioka M, Kaneshiro T, Suzuki S, Kunii H, Saitoh S, Takeishi Y.

Int J Cardiol. 2016 Mar 15;207:368-9. doi: 10.1016/j.ijcard.2016.01.189. Epub 2016 Jan 15. No abstract available.

PMID:
26820370
50.

Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.

Shimizu T, Yoshihisa A, Kanno Y, Takiguchi M, Sato A, Miura S, Nakamura Y, Yamauchi H, Owada T, Abe S, Sato T, Suzuki S, Oikawa M, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Am J Physiol Heart Circ Physiol. 2015 Oct;309(7):H1123-9. doi: 10.1152/ajpheart.00533.2015. Epub 2015 Aug 21.

Supplemental Content

Loading ...
Support Center